Abstract
Heart disease is one of the commonest abnormalities of the fetus and infant. Malformation of the heart is the commonest congenital malformation and accounts for significant morbidity and mortality in utero and postnatally. This chapter gives a brief overview of cardiac development and extensive discussion of the methods of pathological examination of the heart including histological sampling. Congenital heart disease has a reputation as a particularly difficult area of pathology. With care and following a few simple rules, all but the most complex cases can be confidently tackled. All the commoner forms are described and illustrated together with an account of heart disease in the fetus. The cardiomyopathies are covered in detail, especially mitochondrial and metabolic cardiomyopathy. Myocarditis, ischemia and infarction, tumors, and abnormalities of cardiac rhythm are all discussed in detail. Already many gene mutations have been identified for cardiomyopathy and channelopathies in particular and the commoner defects are listed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tam PPL, Schoenwolf GC. Cardiac fate maps: lineage allocation, morphogenetic movement and cell commitment. In: Harvey RP, Rosenthal N, editors. Heart development. London: Academic; 1999. p. 3–18.
Olson EN, Srivastava D. Molecular pathways controlling heart development. Science. 1996;272:671–6.
Gittenberger de Groot AC, Bartelings MM, Deruiter MC, et al. Basics of cardiac development for the understanding of congenital heart malformations. Pediatr Res. 2005;57:169–76.
Kirby ML. Molecular embryogenesis of the heart. Pediatr Dev Pathol. 2002;5:516–43.
Harvey RP. Patterning of the vertebrate heart. Nat Rev Genet. 2002;3:544–56.
Brown N, Anderson RH. Symmetry and laterality in the human heart: developmental implications. In: Harvey RP, Rosenthal N, editors. Heart development. London: Academic; 1999. p. 447–61.
Moorman AFM, Christoffels VM. Cardiac chamber formation: development, genes and evolution. Physiol Rev. 2003;83:1223–67.
Moorman A, Webb S, Brown NA, et al. Development of the heart: (1) formation of the cardiac chambers and arterial trunks. Heart. 2003;89:806–14.
Person AD, Klewer SE, Runyan RB. Cell biology of cardiac cushion development. Int Rev Cytol. 2005;243:287–335.
Anderson RH, Webb S, Brown NA, et al. Development of the heart: (3) Formation of the ventricular outflow tracts, arterial valves, and intrapericardial arterial trunks. Heart. 2003;89:1110–8.
Wessels A, Markman MWM, Vermeulen JLM, et al. The development of the atrioventricular junction in the human heart. Circ Res. 1996;78:10–117.
Rudolph AM. The fetal circulation and postnatal adaptation. In: Rudolph AM, editor. Congenital diseases of the heart: clinical-physiological considerations. 2nd ed. Armonk: Futura Publishing Co; 2001. p. 3–44.
Kondo M, Itoh S, Kunikata T, et al. Time of closure of ductus venosus in term and preterm neonates. Arch Dis Child Fetal Neonatal Ed. 2001;85:F57–9.
Rosenquist GC, Sweeny LJ, Amsel J, et al. Enlargement of the membranous ventricular septum: an internal stigma of Down’s syndrome. J Pediatr. 1974;85:490–3.
Van Pragh R. The segmental approach to diagnosis in congenital heart disease. In: Birth defects: original articles series, vol. 8. Baltimore: Williams & Wilkins; 1972. p. 4–23.
Basso C, Burke M, Fornes P, et al. Association for European Cardiovascular Pathology. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452:11–8.
Goyal VK. Early appearance and rate of lipofuscin pigment accumulation in human myocardium. Exp Gerontol. 1981;16:219–22.
Pesonen E. Extrinsic and intrinsic factors relating to intimal thickening in children. Acta Paediatr Suppl. 2004;446:43–7.
DeSa DJ. Coronary artery ruptures in stillbirths. Pediatr Dev Pathol. 2002;5:605.
Loukas M, Abel M, Tubbs RS, et al. The cardiac lymphatic system. Clin Anat. 2011;24:684–91.
Pryce JW, Bamber AR, Ashworth MT, et al. Reference ranges for organ weights of infants at autopsy: results of >1,000 consecutive cases from a single centre. BMC Clin Pathol. 2014;14:18.
Hill DA, Swanson PE. Myocardial extramedullary haematopoiesis: a clinicopathologic study. Mod Pathol. 2000;13:779–87.
Rowlatt UF, Rimoldi HJA, Lev M. The quantitative anatomy of the normal child’s heart. Pediatr Clin N Am. 1963;10:499–588.
Eckner FAO, Brown BW, Davidson DL, et al. Dimensions of normal human hearts. Arch Pathol Lab Med. 1969;88:497–507.
Jordan SC, Scott O. Incidence, aetiology and recurrence of congenital heart disease. In: Jordan SC, Scott O, editors. Heart disease in paediatrics. 3rd ed. Oxford: Butterworth Heniemann; 1989. p. 3–9.
Arey JB. Malformations of the ventricular septum. In: Arey JB, editor. Cardiovascular pathology in infants and children. Philadelphia: WB Saunders Company; 1984. p. 77–111.
Anderson RH, Lennox CC, Zuberbuhler JR. The morphology of ventricular septal defects. Perspect Pediatr Pathol. 1984;8:235–68.
Alpert BS, Cook DH, Varghese, et al. Spontaneous closure of small ventricular septal defects: ten year follow up. Pediatrics. 1979;63:204–6.
Becker AE, Anderson RH. Atrioventricular septal defects. What’s in a name? J Thorac Cardiovasc Surg. 1982;83:461–9.
Rastelli G, Kirklin JW, Titus JL. Anatomic observations on complete form of persistent common atrioventricular canal with special reference to atrioventricular valves. Mayo Clin Proc. 1966;41:296.
Anderson RH, Ho SY, Falcao S. The diagnostic features of atrioventricular septal defect with common atrioventricular orifice. Cardiol Young. 1998;8:33–49.
Thiene G, Wenink ACG, Frescura C, et al. The surgical anatomy of the conduction tissues in atrioventricular defects. J Thorac Cardiovasc Surg. 1981;82:928–37.
Weintraub RG, Brawn WJ, Venables AW, et al. Two patch repair of complete atrioventricular septal defect in the first year of life: results and sequential assessment of atrioventricular valve function. J Thorac Cardiovasc Surg. 1990;99:320–6.
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent oval foramen during the first decades of life; an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:1489–94.
Fisher DC, Fisher EA, Budd JH, et al. The incidence of patent oval foramen in 1,000 consecutive patients. A contrast transesophageal echocardiography study. Chest. 1995;107:1504–9.
Lee ME, Sade RM. Coronary sinus septal defect. Surgical considerations. J Thorac Cardiovasc Surg. 1979;78:563–9.
Al Zaghal AM, Li J, Anderson RH, et al. Anatomic criteria for the diagnosis of sinus venosus defects. Heart. 1997;78:298–304.
Silver MM, Freedom RM, Silver MD, et al. The morphology of the human newborn ductus arteriosus: a reappraisal of its structure and closure with special reference to prostaglandin E1. Hum Pathol. 1981;12:1123–36.
Rudolph AM. The ductus arteriosus and persistent patency of the ductus arteriosus. In: Rudolph AM, editor. Congenital diseases of the heart: clinical-physiological considerations. 2nd ed. Armonk: Futura Publishing Co; 2001. p. 155–96.
Schiessl B, Schneider KT, Zimmerman A, et al. Prenatal constriction of the fetal ductus arteriosus—related to maternal pain medication. Z Geburtshilfe Neonatol. 2005;209:65–8.
Tynan M. The ductus arteriosus and its closure. N Engl J Med. 1993;329:1570–2.
Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol. 2001;18:1–9.
Lund JT, Hansen D, Brocks V, et al. Aneurysm of the ductus arteriosus in the neonate: three case reports with a review of the literature. Pediatr Cardiol. 1992;13:222–6.
Pellegrino A, Deverall PB, Anderson RH, et al. Aortic coarctation in the first three months of life. Anatomopathological study with respect to treatment. J Thorac Cardiovasc Surg. 1985;89:121–7.
Becker AE, Becker MJ, Edwards JE. Anomalies associated with coarctation of the aorta. Particular reference to infancy. Circulation. 1970;41:1067–75.
Elzenga NJ, Gittenberger de Groot AC. Localised coarctation of the aorta. An age dependent spectrum. Br Heart J. 1983;49:317–23.
Russell GA, Berry PJ, Watterson K, et al. Patterns of ductal tissue in coarctation of the aorta in the first three months of life. J Thorac Cardiovasc Surg. 1991;102:368–9.
Daubeney PE, Delaney DJ, Anderson RH, et al. Pulmonary atresia with intact ventricular septum: range of morphology in a population based study. J Am Coll Cardiol. 2002;39:1670–9.
Gittenberger de Groot AC, Erlap I, Lie-Venema H, et al. Development of the coronary vasculature and its implications for coronary abnormalities in general and specifically in pulmonary atresia without ventricular septal defect. Acta Pediatr Suppl. 2004;93:13–9.
Stamm C, Anderson RH, Ho YS. Clinical anatomy of the normal pulmonary root compared with that in isolated pulmonary valvular stenosis. J Am Coll Cardiol. 1998;31:1420–5.
Sreeram N, Kitchener D, Smith A. Spectrum of valvular abnormalities in Noonan’s syndrome – a pathologic study. Cardiol Young. 1994;4:62–6.
Anderson RH, Allwork SP, Ho SY, et al. Surgical anatomy of tetralogy of Fallot. J Thorac Cardiovasc Surg. 1981;81:887–96.
Emmanouilides GC, Thanopoulos B, Siassi B, et al. Agenesis of ductus arteriosus associated with the syndrome of tetralogy of Fallot and absent pulmonary valve. Am J Cardiol. 1976;37:403–9.
Zhao HX, Miller DC, Reitz BA, et al. Surgical repair of tetralogy of Fallot. Long term follow up with particular emphasis on late death and reoperation. J Thorac Cardiovasc Surg. 1985;89:204–20.
Liao PK, Edwards WD, Julsrud PR, et al. Pulmonary blood supply in patients with pulmonary atresia and ventricular septal defect. J Am Coll Cardiol. 1985;6:1343–50.
Edwards JE. Pathology of left ventricular outflow tract obstruction. Circulation. 1965;31:586–99.
McKay R, Smith A, Leung MP, et al. Morphology of the ventriculoaortic junction in critical aortic stenosis. Implications for hemodynamic function and clinical management. J Thorac Cardiovasc Surg. 1992;104:434–42.
Bartram U, Bartelings MM, Kramer HH, et al. Congenital polyvalvar disease: a review. Pediatr Cardiol. 2001;22:93–101.
Peterson TA, Todd DB, Edwards JE. Supravalvular aortic stenosis. J Thorac Cardiovasc Surg. 1965;50:734–41.
Van Son JAM, Edwards WD, Danielson GK. Pathology of coronary arteries, myocardium and great arteries in supravalvular aortic stenosis. Report of five cases with implications for surgical treatment. J Thorac Cardiovasc Surg. 1994;108:21–8.
Salmon AP. Hypoplastic left heart syndrome – outcome and management. Arch Dis Child. 2001;85:450–1.
O’Connor WN, Cash JB, Cottrill CM. Ventriculocoronary connections in hypoplastic left hearts: an autopsy microscopic study. Circulation. 1992;66:1078–86.
Sauer U, Gittenberger de Groot AC, Geishauser M, et al. Coronary arteries in the hypoplastic left heart syndrome. Histopathologic and histometrical study and implications for surgery. Circulation. 1989;80:I 168–76.
Elzenga NJ, Gittenberger de Groot AC. Coarctation and related aortic arch anomalies in hypoplastic left heart syndrome. Int J Cardiol. 1985;8:379–93.
Allwork SP, Bentall HH, Becker AE, et al. Congenitally corrected transposition of the great arteries: morphologic study of 32 cases. Am J Cardiol. 1976;38:910–23.
Yacoub MH, Radley Smith R. Anatomy of the coronary arteries in transposition of the great arteries and methods of their transfer in anatomical correction. Thorax. 1978;33:418–24.
Anderson RH, Henry GW, Becker AE. Morphologic aspects of complete transposition. Cardiol Young. 1991;1:41.
Collett RW, Edwards JE. Persistent truncus arteriosus: a classification according to anatomic types. Surg Clin N Am. 1949;29:1245–70.
de la Cruz MV, Cayre R, Angelini P, et al. Coronary arteries in truncus arteriosus. Am J Cardiol. 1990;66:1482–6.
Anderson RH, Becker AE, Tynan M, et al. The univentricular atrioventricular connection: getting to the root of a thorny problem. Am J Cardiol. 1984;54:822–8.
Anderson RH, McCarthy K, Cook AC. Double outlet right ventricle. Cardiol Young. 2001;11:329.
DeLisle G, Ando M, Calder AL, et al. Total anomalous pulmonary venous connection: report of 93 autopsied cases with emphasis on diagnostic and surgical considerations. Am Heart J. 1976;91:99–122.
Neill CA, Ferencz C, Sabiston DC, et al. The familial occurrence of hypoplastic right lung with systemic arterial supply and venous drainage. “scimitar syndrome”. Bull Johns Hopkins Hosp. 1960;107:1–15.
Sun C-CJ, Doyle T, Ringel RE. Pulmonary vein stenosis. Hum Pathol. 1995;26:880–6.
Fong LV, Anderson RH, Park SC, et al. Morphologic features of stenosis of the pulmonary veins. Am J Cardiol. 1988;62:1136–8.
Anderson RK, Lie JT. Pathologic anatomy of Ebstein’s anomaly of the heart revisited. Am J Cardiol. 1978;41:739–45.
Rosenquist GC, Sweeny LJ, McAllister HA. Relationship of the tricuspid valve to the membranous septum in Down’s syndrome without endocardial cushion defect: study of 28 specimens, 14 with a ventricular septal defect. Am Heart J. 1975;90:458–62.
Rigby ML, Carvalho JS, Anderson RH, et al. The investigation and diagnosis of tricuspid atresia. Int J Cardiol. 1990;27:1–17.
Uhl HSM. A previously undescribed congenital malformation of the heart: almost total absence of the myocardium of the right ventricle. Bull Johns Hopkins Hosp. 1952;91:197–209.
Corazza G, Soliani M, Bava GL. Uhl’s anomaly in a newborn. Eur J Pediatr. 1981;137:347–52.
Basso C, Bauce B, Corrado D, et al. Pathophysiology of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2012;9:223–33.
Macartney FJ, Zuberbuhler JR, Anderson RH. Morphological considerations pertaining to recognition of atrial isomerism. Consequences for sequential chamber localisation. Br Heart J. 1980;44:657–67.
Melhuish BPP, Van Pragh R. Juxtaposition of the atrial appendages. A sign of severe cyanotic congenital heart disease. Br Heart J. 1968;30:269–84.
Yetman AT, McCrindle BW, McDonald C, et al. Myocardial bridging in children with cardiomyopathy – a risk factor for sudden death. N Engl J Med. 1998;339:1201–9.
Becker AE. Variations of the main coronary arteries. In: Becker AE, Losekoot TG, Marcellettti C, Anderson RH, editors. Paediatric cardiology, vol. 3. Edinburgh: Churchill Livingstone; 1981. p. 263–77.
Neufeld HN, Schneeweiss A. Congenital variations of coronary arteries. In: Neufeld HN, Schneeweiss A, editors. Coronary artery diseases in infants and children. Philadelphia: Lea & Febiger; 1983. p. 65–78.
Ness MJ, McManus BM. Anomalous right coronary origin in otherwise unexplained infant death. Arch Pathol Lab Med. 1988;112:626–9.
Kimbiris D, Iskandrian AS, Segal BL, et al. Anomalous aortic origin of coronary arteries. Circulation. 1978;58:606–15.
Arey JB. Malformations of the coronary vessels. In: Arey JB, editor. Cardiovascular pathology in infants and children. Philadelphia: WB Saunders Company; 1984. p. 204–17.
Buirsky G, Jordan SC, Joffe HS, et al. Superior vena caval abnormalities: their occurrence rate, associated cardiac abnormalities and angiographic classification in a paediatric population with congenital heart disease. Clin Radiol. 1986;37:131–8.
Cantrell JR, Haller JA, Ravitch MM. A syndrome of congenital defects involving the abdominal wall, sternum, diaphragm, pericardium and heart. Surg Gynecol Obstet. 1958;107:602–14.
Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–900.
Gill HK, Splitt M, Sharland GK, et al. Patterns of recurrence of congenital heart disease: an analysis of 6,640 consecutive pregnancies evaluated by detailed fetal echocardiography. J Am Coll Cardiol. 2003;42:923–9.
Poon LC, Huggon IC, Zidere V, et al. Tetralogy of Fallot in the fetus in the current era. Ultrasound Obstet Gynecol. 2007;29:625–7.
Rodriguez JG, Holmes R, Martin R, et al. Prognosis following prenatal diagnosis of heart malformations. Early Hum Dev. 1998;52:13–20.
Hornberger LK, Sanders SP, Azaria JJT, et al. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus: a longitudinal study. Circulation. 1995;92:1531–8.
Yamamoto Y, Hornberger LK. Progression of outflow tract obstruction in the fetus. Early Hum Dev. 2012;88:279–85.
Maeno YV, Boutin C, Hornberger LK, et al. Prenatal diagnosis of right ventricular outflow tract obstruction with intact ventricular septum, and detection of ventriculocoronary connections. Heart. 1999;81:661–8.
Chew C, Halliday JL, Riley MM. Population based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound Obstet Gynecol. 2007;29:619–24.
Allan LD, Sharland GK, Milburn A, et al. Prospective diagnosis of 1,006 consecutive cases of congenital heart disease in the fetus. J Am Coll Cardiol. 1994;23:1452–8.
Hoffman JIE. Incidence of congenital heart disease, II: prenatal incidence. Pediatr Cardiol. 1995;16:155–65.
Eronen M. Outcome of fetuses with heart disease diagnosed in utero. Arch Dis Child. 1997;77:F41–6.
Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics. 2005;116:e833–8.
Corrigan N, Brazil DP, McAuliffe F. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol. 2009;85:523–30.
Yates RS. The influence of prenatal diagnosis on postnatal outcome in patients with structural congenital heart disease. Prenat Diagn. 2004;24:1143–9.
Allan LD. Rationale for and current status of prenatal cardiac intervention. Early Hum Dev. 2012;88:287–90.
Donofrio MT, Duplessis AJ, Limperopoulos C. Impact of congenital heart disease on fetal brain development and injury. Curr Opin Pediatr. 2011;23:502–11.
McQuillen PS, Miller SP. Congenital heart disease and brain development. Ann N Y Acad Sci. 2010;1184:68–86.
Simchen MJ, Toi A, Silver M, et al. Fetal cardiac calcifications: report of four prenatally diagnosed cases and review of the literature. Ultrasound Obstet Gynecol. 2006;27:325–30.
McFadden DE, Taylor GP. Cardiac abnormalities and nonimmune hydrops fetalis: coincidental, not causal, relationship. Pediatr Pathol. 1989;9:11–7.
Siven M, Ley D, Hagerstrand I, et al. Agenesis of the ductus venosus and its correlation to hydrops fetalis and the hepatic fetal circulation: case reports and review of the literature. Pediatr Pathol Lab Med. 1995;15:39–50.
Zuberbuhler JR, Neches WH, Park SC. Infectious endocarditis – an experience spanning three decades. Cardiol Young. 1994;4:244–51.
Fowler VG, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. J Am Med Assoc. 2005;293:3012–21.
Choi M, Mailman TL. Pneumococcal endocarditis in infants and children. Pediatr Infect Dis J. 2004;23:166–71.
Arey JB. Diseases of the endocardium, myocardium and pericardium. In: Arey JB, editor. Cardiovascular pathology in infants and children. Philadelphia: WB Saunders; 1984.
Morrow WR, Haas JE, Benjamin DR. Nonbacterial endocardial thrombosis in neonates: relationship to persistent fetal circulation. J Pediatr. 1982;100:117–22.
Favara BE, Franciosi RA, Butterfield LJ. Disseminated intravascular and cardiac thrombosis of the neonate. Am J Dis Child. 1974;127:197–204.
Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343:1388–98.
Kim KS, Hufnagel G, Chapman NM, et al. The group B Coxsackieviruses and myocarditis. Rev Med Virol. 2001;11:355–68.
Baboonian C, Davies MJ, Booth J, et al. Coxsackie B viruses and heart disease. Curr Top Microbiol Immunol. 1997;233:31–52.
Keesler MJ, Fisher SD, Lipschultz SE. Cardiac manifestations of HIV infections in infants and children. Ann N Y Acad Sci. 2001;946:169–78.
Weber MA, Ashworth MT, Risdon RA, et al. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch Dis Child. 2008;93:594–8.
O’Malley A, Barry-Kinsella B, Hughes C, et al. Parvovirus infects cardiac myocytes in hydrops fetalis. Pediatr Dev Pathol. 2003;5:414–20.
Munro K, Croxson MC, Thomas S, et al. Three cases of myocarditis in childhood associated with human parvovirus (B19 virus). Pediatr Cardiol. 2003;24:473–5.
Wasi J, Shuter J. Primary bacterial infection of the myocardium. Front Biosci. 2003;8:s228–31.
Rosenberg HS. Cardiovascular effects of congenital infections. Am J Cardiovasc Pathol. 1987;1:147–56.
Beardsall K, White DK, Pinto EM, et al. Pericardial effusions and cardiac tamponade as a complication of neonatal long lines. Arch Dis Child Fetal Neonatal Ed. 2003;88:F292–5.
Tani LY, Veasy LG, Minich LL, et al. Rheumatic fever in children younger than 5 years: is the presentation different? Pediatrics. 2003;112:1065–8.
Bamber AR, Pryce J, Cook A, et al. Myocardial necrosis and infarction in newborns and infants. Forensic Sci Med Pathol. 2013;9:521–7.
Chaoui R. Coronary arteries in fetal life: physiology, malformations and the “heart-sparing effect”. Acta Paediatr Suppl. 2004;446:6–12.
Makikallio K, Vuolteenaho O, Jouppila P, et al. Ultrasonic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation. 2002;105:2058–63.
Young NA, Mondestin MAJ, Bowman RL. Ischaemic changes in fetal myocardium. An autopsy series. Arch Pathol Lab Med. 1994;118:289–92.
DeSa DJ. Coronary arterial lesions and myocardial necrosis in stillbirths and infants. Arch Dis Child. 1979;54:918–30.
Topaz O. Myocardial calcification in neonates and infants. A unique tissue reaction. South Med J. 1991;84:891–5.
Tennstedt C, Chaoui R, Vogel M, et al. Pathologic correlation of echogenic foci in the fetal heart. Prenat Diagn. 2000;20:287–92.
Lazda EJ, Batchelor WH, Cox PM. Immunohistochemical detection of myocardial necrosis in stillbirth and neonatal death. Pediatr Dev Pathol. 2000;3:40–7.
Fishbein MC, Wang T, Matijasevic M, et al. Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia. Cardiovasc Pathol. 2003;12:65–71.
Richardson P, McKenna W, Bristow M, et al. Report of the World Health Organisation/International Society and Federation of cardiology Task Force on the definitions and classification of cardiomyopathies. Circulation. 1996;93:841–2.
Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113:1807–16.
Wigle ED, Rakowski H, Kimball BP, et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995;92:1680–92.
Redwood CS, Moolman-Smook J, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20–36.
Ahmad F, Seidman JG, Seidman CE. The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet. 2005;6:185–216.
McKenna WJ, Coccolo F, Elliott PM. Genes and disease expression in hypertrophic cardiomyopathy. Lancet. 1998;352:1162–3.
Geier C, Gehmlich K, Ehler E, et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum Mol Genet. 2008;17:2753–65.
Friedrich FW, Wilding BR, Reischmann S, et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet. 2012;21:3237–54.
Servidei S, Bertini E, DiMauro S. Hereditary metabolic cardiomyopathies. Adv Pediatr. 1994;41:1–32.
Arad M, Moskowitz IP, Patel VV, et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. 2002;109:357–62.
Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005;352:362–72.
Dutka DP, Donnelly JE, Nihoyannopoulos P, et al. Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart. 1999;81:141–7.
Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2005;6:45–68.
McMahon JN, Berry PJ, Joffe HS. Fatal hypertrophic cardiomyopathy in an infant of a diabetic mother. Pediatr Cardiol. 1990;11:211–2.
Israel BA, Sherman FS, Guthrie RD. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol. 1993;10:307–10.
Gilbert-Barness G, Barness LA. Nonmalformative cardiovascular pathology in infants and children. Pediatr Dev Pathol. 1999;2:499–530.
Badorff C, Lee G-H, Lamphear BJ, et al. Enteroviral protease 2A cleaves dystrohpin: evidence of cytoskeletal disruption in acquired cardiomyopathy. Nat Med. 1999;5:320–5.
Zatuchni J, Aegerter EE, Molthan L, et al. The heart in progressive muscular dystrophy. Circulation. 1961;111:846–53.
Schwartz ML, Cox GF, Lin AE, et al. Clinical approach to genetic cardiomyopathy in children. Circulation. 1996;94:2021–38.
Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343:1688–96.
Graham RM, Owens WA. Pathogenesis of inherited forms of dilated cardiomyopathy. N Engl J Med. 1999;341:1759–62.
Price DI, Stanford LC, Braden DS, et al. Hypocalcemic rickets: an unusual cause of dilated cardiomyopathy. Pediatr Cardiol. 2003;5:510–2.
Chang KTE, Taylor GP, Meschino WS, et al. Mitogenic cardiomyopathy: a lethal neonatal familial cardiomyopathy characterized by myocyte hyperplasia and proliferation. Hum Pathol. 2010;41:1002–8.
Shenje LK, Andersen P, Halushka MK, et al. Mutations in Alström protein impair terminal differentiation in cardiomyocytes. Nat Commun. 2014;5:3416.
Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997;336:267–76.
Russo LM, Webber SA. Idiopathic restrictive cardiomyopathy in children. Heart. 2005;91:1199–202.
Hughes SE, McKenna WJ. New insights into the pathology of inherited cardiomyopathy. Heart. 2005;91:257–64.
Selcen D, Ohno K, Engel AG. Myofibrillary myopathy: clinical, morphological and genetic studies in 63 patients. Brain. 2004;127:439–51.
D’Amati G, Leone O, diGioia CR, et al. Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns. Hum Pathol. 2001;32:1078–86.
Ursell PC. Noncompaction in the fetus and neonate: an autopsy study. Am J Med Genet. 2013;163C:169–77.
Burke A, Mont E, Kutys R, et al. Left ventricular noncompaction: a pathological study of 14 cases. Hum Pathol. 2005;36:403–11.
Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet. 1997;61:868–72.
Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterisation of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation. 2003;108:2672–8.
Wong JA, Bofinger MK. Noncompaction of the left ventricular myocardium in Melnick-Needles syndrome. Am J Med Genet. 1997;71:72–5.
Karatza AA, Holder SE, Gardiner HM. Isolated non-compaction of the ventricular myocardium: prenatal diagnosis and natural history. Ultrasound Obstet Gynecol. 2003;21:75–80.
Malhotra V, Ferrans VJ, Virmani R. Infantile histiocytoid cardiomyopathy: three cases and literature review. Am Heart J. 1994;128:1009–21.
Shehata BM, Patterson K, Thomas JE, et al. Histiocytoid cardiomyopathy: three new cases and review of the literature. Pediatr Dev Pathol. 1998;1:56–69.
Vallance HD, Jeven G, Wallace DC, et al. A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344 G (MERRF) mitochondrial DNA mutation. Pediatr Cardiol. 2004;25:538–40.
Finsterer J. Histiocytoid cardiomyopathy: a mitochondrial disorder. Clin Cardiol. 2008;31:225–7.
Bird LM, Krous HF, Eichenfield LF, et al. Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy? Am J Med Genet. 1994;53:141–58.
Shehata BM, Bouzyk M, Agrwal V, et al. Whole exome DNA sequences of histiocytoid cardiomyopathy patients and first degree family members – reporting two new genes confirming inheritance patterns in histiocytoid cardiomyopathy. Pediatr Dev Pathol. 2013;16:129.
Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ, et al. Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy. J Inherit Metab Dis. 1997;20:674–9.
Marin-Garcia J, Goldenthal MJ. Mitochondrial cardiomyopathy: molecular and biochemical analysis. Pediatr Cardiol. 1997;18:251–60.
Terman A, Brunk UT. Autophagy in cardiac myocyte homeostasis, aging and pathology. Cardiovasc Res. 2005;68:355–65.
Taylor GP. Neonatal mitochondrial cardiomyopathy. Pediatr Dev Pathol. 2004;7:620–4.
Cochat P. Combined liver kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr. 1999;158:S75–80.
Hayflick S, Rowe S, Kavanaugh-Mc Hugh A, et al. Acute infantile cardiomyopathy as a presenting feature of mucopolysaccharidosis. J Pediatr. 1992;12:269–72.
Gilbert-Barness E. Cardiovascular involvement in metabolic diseases. Pediatr Pathol Mol Med. 2002;21:93–136.
Pernot C, Loth P, Gautier M. The myocardiopathies of glycogenosis. Arch Mal Coeur Vaiss. 1978;71:428–36.
VanNoort G, Straks W, Van Diggelen OP, et al. A congenital variant of glycogenosis type IV. Pediatr Pathol. 1993;13:685–98.
Miranda AF, Nette G, Hartlage P, et al. Phosphorylase isoenzymes in normal and myophosphorylase deficient human heart. Neurology. 1979;29:1538–41.
Kelley RI, Cheatham JP, Clark BJ, et al. X-linked dilated cardiomyopathy with neutropenia, growth retardation and 3-methylglutaconic aciduria. J Pediatr. 1991;119:738–47.
Gehrmann J, Sohlbach K, Linnebank M, et al. Cardiomyopathy in congenital disorders of glycosylation. Cardiol Young. 2003;13:345–51.
Nadas AS, Ellison RC. Cardiac tumors in infancy. Am J Cardiol. 1968;21:363–6.
Burke A, Virmani R. Classification and incidence of cardiac tumors. In: Burke A, Virmani R, editors. Atlas of tumor pathology 3rd series, Fascilce 16, tumors of the heart and great vessels. Washington DC: AFIP; 1995. p. 1.
Isaacs Jr H. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004;25:252–73.
Sallee D, Spector ML, Heerkeren DW, et al. Primary pediatric cardiac tumors: a 17 year experience. Cardiol Young. 1999;9:155–62.
Yinon Y, Chitayat D, Blaser S, et al. Fetal cardiac tumors: a single-center experience of 40 cases. Prenat Diagn. 2010;30:941–9.
Beghetti M, Gow RM, Haney I, et al. Pediatric benign primary cardiac tumours: a 15-year review. Am Heart J. 1997;134:1107–14.
Isaacs H. Perinatal (fetal and neonatal) tuberous sclerosis: a review. Am J Perinatol. 2009;26:755–60.
Tworetzky W, McElhinney DB, Margossian R, et al. Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol. 2003;92:487–9.
Tehrani M, Vettraino IM, Chang CH. Localized nodular hypertrophy mimicking rhabdomyoma in the fetal heart: prenatal sonographic and pathology findings. Pediatr Dev Pathol. 2004;7:192–7.
Burke AP, Rosada-de-Christenson M, Templeton PA, et al. Cardiac fibroma: clinicopathologic correlates and surgical treatment. J Thorac Cardiovasc Surg. 1994;108:862–70.
Heerema-McKenney A, Harrison MR, Bratton B, et al. Congenital teratoma: a clinicopathologic study of 22 fetal and neonatal tumors. Am J Surg Pathol. 2005;29:29–38.
Amano J, Kono T, Wada Y, et al. Cardiac myxoma: its origin and tumor characteristics. Ann Thorac Cardiovasc Surg. 2003;9:215–21.
Watanabe M, Abe M, Ogawa S. A case of neonatal cardiac tamponade associated with benign hemangioma. J Nippon Med Sch. 2010;77:2–3.
Daubeney PE, Ogilvie BC, Moore IE, et al. Intrapericardial lymphangioma presenting as neonatal cardiac tamponade. Pediatr Cardiol. 1996;17:129–31.
Kobayashi D, Delius RE, Debelenko LV, et al. Cardiac juvenile xanthogranuloma in an infant presenting with pericardial effusion. Congenit Heart Dis. 2013;8:E106–10.
Burke A, Virmani R. Pediatric heart tumors. Cardiovasc Pathol. 2008;17:193–8.
Keeling JW. Iatrogenic disease in the newborn. Virchows Archiv A. 1981;349:1–29.
ter Heide H, Strander-Stumpel CT, Pals G, et al. Neonatal Marfan syndrome: clinical report and review of the literature. Clin Dysmorphol. 2005;14:81–4.
Luschner TF, Lie JT, Aw S, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;69:931–52.
Price RA, Vawter G. Arterial fibromuscular dysplasia in infancy and childhood. Arch Pathol. 1972;93:419–26.
Arey JB, Segal R. Fibromuscular dysplasia of the intramyocardial coronary arteries. Pediatr Pathol. 1987;7:97–103.
Imamura M, Yokoyama S, Kikuchi K. Coronary fibromuscular dysplasia presenting as sudden infant death. Arch Pathol Lab Med. 1997;121:159–61.
Billingham ME. Normal heart. In: Sternberg SS, editor. Histology for pathologists. New York: Raven Press; 1992. p. 215–31.
Maron BJ, Wolfson JK, Epstein SE, et al. Intramural (“small-vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545–7.
Burke AP, Ribe JK, Ak B, et al. Hamartoma of mature cardiac myocytes. Hum Pathol. 1998;29:904–9.
Fortuin NJ, Morrow AG, Roberts WC. Late vascular manifestations of the rubella syndrome. A roentgenographic-pathologic study. Am J Med. 1971;51:134–40.
Greene JF, Fitzwater JE, Burgess J. Arterial lesions associated with neurofibromatosis. Am J Clin Pathol. 1974;62:481–7.
Rolfes DB, Towbin R, Bove KE. Vascular dysplasia in a child with tuberous sclerosis. Pediatr Pathol. 1985;3:359–73.
Marrott PK, Newcombe KD, Becroft DM, et al. Idiopathic infantile arterial calcification with survival to adult life. Pediatr Cardiol. 1984;5:119–22.
Morton R. Idiopathic arterial calcification in infancy. Histopathology. 1978;2:423–32.
Farquhar J, Makhseed N, Sargent, et al. Idiopathic infantile arterial calcification and persistent pulmonary hypertension. Am J Perinatol. 2005;22:121–5.
Rutsch F, Ruf N, Vaingankar S, et al. Mutations in ENPP1 are associated with “idiopathic” infantile arterial calcification. Nat Genet. 2003;34:378–81.
Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004;16:508–14.
Anderson RH, Ho SY, Smith A, et al. Study of the cardiac conduction tissues in the paediatric age group. Diagn Histopathol. 1981;4:3–15.
James TN. Cardiac conduction system: fetal and postnatal development. Am J Cardiol. 1970;25:213–26.
Feldt RH, DuShane JW, Titus JL. The atrioventricular conduction system in persistent common atrioventricular canal defect. Circulation. 1970;42:437–44.
Lev M, Bharati S. Lesions of the conduction system and their functional significance. Pathol Annu. 1974;9:157–207.
Ho SY, Esscher E, Anderson RH, et al. Anatomy of congenital complete heart block and relation to maternal anti-ro antibodies. Am J Cardiol. 1986;58:291–4.
Llanos C, Friedman DM, Saxena A, et al. Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus. Rheumatology. 2012;51:1086–92.
Cuneo BF, Fruitman D, Benson DW, et al. Spontaneous rupture of atrioventricular valve tensor apparatus as late manifestation of anti-Ro/SSA antibody-mediated cardiac disease. Am J Cardiol. 2011;107:761–6.
Wever EF, Robles de Medina EO. Sudden death in patients without structural heart disease. J Am Coll Cardiol. 2004;43:1137–44.
Antzelevitch C. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children. J Electrocardiol. 2003;34:177–81.
Francis J, Sankar V, Nair VK, et al. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2005;2:550–4.
Priori SG, Wilde AA, Horie M, et al. HRS/EHRA/APHRS Expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm. 2013;10:1932–63.
Skinner JR. Sudden unexplained death in infancy and long QT syndrome. Curr Pediatr Rev. 2010;6:48–55.
Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286:2264–9.
Tester DJ, Ackerman MJ. Sudden infant death syndrome: how significant are the cardiac channelopathies? Cardiovasc Res. 2005;67:388–96.
Cronk LB, Ye B, Kaku T, et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm. 2007;4:161–6.
Van Norstrand DW, Valdivia CR, Tester DJ, et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation. 2007;116:2253–9.
Van Norstrand DW, Medeiros-Domingo A, Tester DJ, et al. Missense mutations in SNTA1-encoded syntrophin alpha and sudden infant death syndrome. Circulation. 2008;118:S812–3.
Tan HL, Hofman N, van Langen IM, et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation. 2005;112:207–13.
Tester DJ, Dura M, Carturan E, et al. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm. 2007;4:733–9.
Tester DJ, Tan B-H, Medeiros-Domingo A, et al. Loss-of function mutations in the KCNJ8-encoded Kir6.1 KATP channel and sudden infant death syndrome. Circ Cardiovasc Genet. 2011;4:510–5.
Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long QT syndrome gene variations in sudden infant death syndrome. Circulation. 2007;115:361–7.
Manasek FJ, Icardo J, Nakamura A, et al. Cardiogenesis: developmental mechanisms and embryology. In: Fozzard HA, Haber E, Jennings RB, et al., editors. The heart and cardiovascular system. New York: Raven Press; 1986. p. 965–85.
Rigby ML, Shinebourne EA. Development of the cardiovascular system. Functional development. In: Davis JA, Dobbing J, editors. Scientific foundations of paediatrics. London: Butterworth-Heinemann Ltd; 1981. p. 373–89. Elsevier.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing
About this chapter
Cite this chapter
Ashworth, M.T. (2015). The Cardiovascular System. In: Khong, T.Y., Malcomson, R.D.G. (eds) Keeling’s Fetal and Neonatal Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-19207-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-19207-9_19
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19206-2
Online ISBN: 978-3-319-19207-9
eBook Packages: MedicineMedicine (R0)